Prostate Cancer
The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer - Abstract
May 13, 2013
Four new drugs on the market: Abiraterone, belatacept, vandetanib and fidaxomycine - Abstract
May 10, 2013